Clarivate Epidemiology’s coverage of Huntington’s disease (HD) comprises epidemiological estimates of key patient populations in emerging markets (Brazil, Russia, India, China, Mexico, Turkey, and South Korea). We report the prevalence of HD for each country, as well as annualized case counts projected to the national population.
Clarivate Epidemiology’s HD forecast will answer the following questions:
All forecast data are available on the Clarivate Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.
In addition to the diagnosed prevalent cases, Clarivate Epidemiology forecasts data for the following HD populations:
Note: Coverage may vary by country.